Home > PJ (current issue)> Contract 2005

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7317 p385
18 September 2004

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Contract 2005

What the new contract has in store

This is the first article in a new series that will provide an overview of the services that community pharmacists will be expected to offer under the new community pharmacy contract in England and Wales. Clare Bellingham (on the staff of The Journal) starts the series by reviewing the overall structure of the new contract

Contract 2005 series


Scotland

Community pharmacists in Scotland will also be getting a new contract in 2005 but it will differ from that in England and Wales. A future series of articles will examine the new contract in Scotland.

Early in 2005, community pharmacists in England and Wales will have a new NHS contract. Although the implementation date is still to be finalised, January looks probable. In the run up to implementation, this series of articles will examine each of the new services that pharmacists will be expected to provide under the new contract. (“Pharmacy contract” is used to describe the new contractual framework which, as with the current arrangements, will be national arrangements laid down in secondary legislation.)

Pharmacists’ current contract was agreed in 1987 and is now out of step with developments in pharmacy and the NHS. The old contract focused on throughput of a high volume of prescriptions. The new contract has different aims: it will reward high quality services, harness the skills of pharmacists and pharmacy staff, and provide minimum standards for pharmacy.

Basic structure

Key points

1. Community pharmacists will be working under the new contractual framework in early 2005

2. The new contract is focused on high quality services rather than dispensing large volumes of prescriptions

3. The new contract is made of three tiers: essential, advanced and enhanced services

4. All contractors will be expected to provide essential services and eventually it is hoped that all will provide advanced services

5. Enhanced services are commissioned locally by PCTs although a national specification for each service will be drawn up

The new contract is formed of three tiers: essential services, advanced services and enhanced services.

All contractors will be expected to offer essential services. Advanced services will require accreditation of the pharmacist, the pharmacy premises or both. These two tiers form the national pharmacy contract.

On top is the third tier of enhanced services. Although a service specification and value will be agreed nationally for each enhanced service, they will be commissioned locally by primary care trusts.

The contract structure is expected to develop over time, so those services currently classified as enhanced services could be moved to either the essential or the advanced sections of the contract.

Funding for the nationally contracted essential and advanced services has now been agreed. In August, the Pharmaceutical Services Negotiating Committee accepted a £1.766bn deal from the Department of Health to fund the contract in England (PJ, 28 August, p277). An announcement on how this sum will be distributed to individual contractors is expected to be made next week. Funding for the contract in Wales should also be announced imminently.

Essential services

There are seven essential services. They must be provided by all community pharmacy contractors and are not open to local negotiation.

First is dispensing. Dispensing covers the supply of medicines and appliances, and the provision of advice about the medicines dispensed and about possible interactions with other medicines. It also includes making a record of what has been dispensed and possibly the advice given (this will be decided within the next few weeks). The dispensing service will also include the provision of compliance aids needed by patients with disabilities. The next essential service is repeat dispensing. This will operate along the lines of the repeat dispensing pilots.

Clinical governance is an essential requirement for the contract. Contractors will be expected to ensure that standard operating procedures are used, that adverse incidents are reported to the National Patient Safety Agency, that continuing professional development is undertaken by pharmacists, that services are audited, that patient satisfaction questionnaires are carried out and that interventions are monitored.

Another essential service is in public health. This will include opportunistic one-to-one counselling on smoking cessation and coronary heart disease risk factors, promoting vaccination against influenza and providing education about appropriate use of antibiotics.

Signposting patients to other health care providers is also an essential service. Linked to this is support for self-care; this essential service will include receiving referrals from NHS Direct and provision of advice to patients on treatment of minor ailments, thus reducing burdens on GPs.

The final essential service is medicines waste disposal.

Advanced services

The second tier of the contract is advanced services. In order to provide them, pharmacists will have to be accredited or the pharmacy premises will have to fulfil certain requirements. Although part of the national contractual framework, not all contractors are likely to provide advanced services from day one because of the additional requirements. However, it is hoped that, in time, all contractors will provide advanced services.

There are two advanced services: medicines use review and a prescription intervention service.

The medicines use review involves a pharmacist undertaking a face-to-face review with a patient. The review will be concordance-centred and identify any problems the patient has with his or her current medication and then address these problems. It will also examine the patient’s knowledge of his or her medication and help the patient to develop this knowledge. Information will then be fed back to the patient’s GP.

The prescription intervention service is similar to the medicines use review but is initiated differently. Instead of a planned review, the prescription intervention service will be a review triggered by a pharmacist identifying a significant issue with a patient’s prescription.

Enhanced services

Enhanced services will be commissioned locally by primary care trusts. A service specification and value — either in pounds or, like the new GP contract, in points — will be agreed nationally but PCTs will be able to vary these according to local needs.

Because enhanced services are commissioned, how many of them a particular pharmacy provides will be determined by local needs so a definitive list of all the enhanced services pharmacists could offer is impossible to determine. However, some examples of enhanced services that are expected to be commonplace are:

· Minor ailments management
· Diabetes screening
· Substance misuse services
· Coronary heart disease screening
· Disease-specific medicines management
· Palliative care services
· Emergency hormonal contraception
· Full clinical medication review (ie, “Room for Review” level three)
· Concordance services
· Out-of-hours services
· Care home and intermediate care services
· Prescriber support services
· Domiciliary assessments
· Head lice management
· Smoking cessation service
· Gluten-free food supply service

Back to Top


©The Pharmaceutical Journal